1-6 of 6
group practice
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care 1995 - 2017

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Hubert Köppler, Prof., Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4823.
https://doi.org/10.1182/blood-2018-99-109862
Published: 2018
Journal Articles

Identifying Clinical Gaps in the Diagnosis, Monitoring, and Management of Immunoglobulin Light Chain (AL) Amyloidosis Among Hematologist/Oncologists

Emily S Van Laar, Morie A. Gertz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4672.
https://doi.org/10.1182/blood.V130.Suppl_1.4672.4672
Published: 2017
Journal Articles

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care. a Retrospective Analysis of All Patients with CLL Who Were Treated in an Oncology Group Practice in Germany Between 1995-2015

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD, Hubert Köppler, Prof.
Journal: Blood
Blood (2016) 128 (22): 5961.
https://doi.org/10.1182/blood.V128.22.5961.5961
Published: 2016
Journal Articles

Standard of Care of Patients with CML Treated in Community Based Oncology Group Practices in Rhineland-Palatinate (Germany)

Rudolf Weide, Prof., Bernhard Rendenbach, MD, Monika Grundheber, MD, Oswald Burkhard, MD, Joachim Behringer, MD, Michael Maasberg, MD, Peter Ehscheidt, MD, John Werner Strehl, MD, Richard Hansen, MD, Stefan Feiten
Journal: Blood
Blood (2016) 128 (22): 2376.
https://doi.org/10.1182/blood.V128.22.2376.2376
Published: 2016
Journal Articles

Impact of Molecular Testing for JAK2 V617F in the Diagnosis of Polycythemia in An Integrated Community Based Hematology/Oncology Group Practice

Paul I. Roda, MD, Erlich Porat, Phd, MPH
Journal: Blood
Blood (2011) 118 (21): 846.
https://doi.org/10.1182/blood.V118.21.846.846
Published: 2011
Journal Articles

Treatment of Higher-Risk Myelodysplastic Syndrome (MDS) by American Hematology-Oncology Providers (AHOP's): Changes in 1st-Line Treatment Preferences Over Time in Relation to Cytogenetics & Survival Data From Randomized Studies (2006–2010),

James M. Foran, MD, FRCPC, Michael G. Heckman, MS, Michael E. Williams, MD, Joanne Willey, RN, Mark R. Green, MD
Journal: Blood
Blood (2011) 118 (21): 3816.
https://doi.org/10.1182/blood.V118.21.3816.3816
Published: 2011